BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2010
View Archived Issues
Preclinical activity of LY-S6KAKT1 justifies entry into phase I trial as cancer therapy
Read More
GlaxoSmithKline claims new inhibitors of focal adhesion kinase 1
Read More
High Point Pharma patents new beta-secretase 1 inhibitors
Read More
Roche describes novel inverse agonists of GABA(A) receptor
Read More
Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing
Read More
Phase I data presented on MEDI-573 and MEDI-575 in advanced solid tumors
Read More
Pfizer's AadAT inhibitor PF-4859989 shows activity in vivo
Read More
Atrasentan reduces albuminuria in patients with diabetes-associated nephropathy
Read More
Elan presents new antagonists of integrin alpha-4/beta-7
Read More
FDA clears design of phase III oritavancin trials SOLO-1 and -2
Read More
UCB updates progress from third quarter of 2010
Read More
Ohio State University claims new inhibitors of prostaglandin G/H synthase 2
Read More
Immunovaccine and OncoTherapy Science join to develop cancer vaccine
Read More
Renhuang Pharmaceuticals changes name to China Botanic Pharmaceutical
Read More
Optimer Pharma submits NDA for fidaxomicin to FDA and requests priority review
Read More
Pfizer's phase III axitinib trial in renal cell carcinoma meets primary endpoint
Read More
Tamir Biotechnology compounds show encouraging in vitro activity against HPV
Read More
Transition Therapeutics and Elan amend agreement on scyllo-inositol
Read More
Anacor, UCSF and LFKRI team up to discover onchocerciasis therapies
Read More
ACT files IND for phase I/II trial of MA-09-HRPE in dry AMD
Read More
NanoBio receives grant to develop vaccine against RSV infection
Read More
Savient Pharma's Krystexxa is available by prescription in U.S.
Read More
Ikaria begins pivotal phase III Lucassin trial in hepatorenal syndrome type 1
Read More
Accentia forms strategic alliance with Baxter
Read More
CBLB-502 receives FDA orphan drug status for prevention of death following irradiation
Read More